维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="DI MARTINO MT"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma:in vitro and in vivo evidence显示文摘	Di Martino MT Leone E Amodio N	2012	Clin Cancer Res2012，18，：	1
2	Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth 显示文摘	LEONE E MORELLI E DI MARTINO MT	2013	Clin Cancer Res2013，19，8：	1
3	Transferrin-conjugated SNALPs encapsulating 2'-O-methylated miR-34a for the treatment of multiple myeloma显示文摘	Scognamiglio I Di Martino MT Campani V	2014	Biomed Res Int2014，2014，21：	1
4	miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1显示文摘	Amodio N Di Martino MT Foresta U	2012	Cell Death Dis2012，3，：	1
5	In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid,a histone deacetylase inhibitor显示文摘	Neri P Tagliaferri P Di Martino MT		0，，04：	1
6	Non-coding RNA:a novel opportunity for the personalized treatment of multiple myeloma显示文摘	Amodio N Di Martino MT Neri A	2013	Expert Opin Biol Ther2013，13，1：	1
7	In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma显示文摘	Di Martino MT Gull A Cantafio ME eta/	2013	Oncotarget2013，4，2：	1
8	Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study显示文摘	Di Martino MT Arbitrio M Leone E	2011	Cancer Bioi Ther2011，12，9：	1
9	Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xeno- grafts in vivo显示文摘	TASSONE P DI MARTINO MT VENTURA M	2009	Cancer Biol Ther2009，8，：	1
10	Biological andclinical relevance of miRNA expression signatures in primaryplasma cell leukemia 显示文摘	Lionetti M Musto P Di Martino MT	2013	Clin Cancer Res2013，19，12：	1
11	In vitro and in vivo anti- tumor activity of miR-221/222 inhibitors in multiple myeloma 显示文摘	Di Martino MT Gulla A Cmltafio ME	2013	Oncotarget2013，4，2：	1
12	Promises and challenges of MicroRNA-based treatment of multiple myeloma显示文摘	Tagliaferri P Rossi M Di Martino MT	2012	Curr Cancer Drug Targets2012，12，：	1
13	Mir-34:a new weapon against cancer?显示文摘	Misso G Di Martino MT De Rosa G	2014	Mol Ther Nucleic Acids2014，3，9：	1
14	In vivo anti - myeloma activity and modulation of gene expression profile induced by val- proic acid, a histone deacetylase inhibitor 显示文摘	Neff P Tagliaferri P Di Martino MT	2008	Br J Haematol2008，143，：	1
15	Molecular targets for the treatment of multiple myeloma显示文摘	Rossi M Di Martino MT Morelli E	2012	Curr Cancer Drug Targets2012，12，7：	1
16	Molecular targets for the treatment of multiple myeloma显示文摘	Rossi M Di Martino MT Morelli E etal	2012	Curt Cancer Drug Targets2012，12，7：	1
17	Loss of BRCA1 function increases the antitumor activity of cisplatin a- gainst human breast cancer xenografts in vivo显示文摘	Tassone P Di Martino MT Ventura M	2009	Cancer Biol T- her2009，8，7：	1
18	Mir-221/222are promising targets for innovative anticancer therapy显示文摘	Di Martino MT Rossi M Caracciolo D	2016	Expert OpinTher Targets2016，21，：	1
19	EDTA is es-sential to recover lead from dried blood spots on filter paper显示文摘	Di Martino MT Michniewicz A Martucci M	2004	Clin Chim Acta2004，350，12：	1
20	Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo显示文摘	Tassone P Di Martino MT Ventura M	2009	Cancer Biol Ther2009，8，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示